Oversold

TCMD

Valuation71/ 100
Cash flow & growth79/ 100
Upside potential55/ 100
Risk potential37/ 100

TCMD's valuation is historically cheap, fundamentals are above averages, but expected margin pressure limits the outlook, though analyst coverage is limited.

Score change since last week

The score rose 1 point, mainly due to valuation and price changes. Price fell 5.6%, from $23.16 to $21.87. Reported EPS was unchanged, so the lower price improved valuation support.

Valuation and price changes added 0.7 points. The comparison uses the same available inputs on both dates. Displayed changes are rounded to whole points.

Valuation

Historical cheapness: current PE is 20.3× versus the full-history median of 27.7× shown in the valuation table, producing 70.1/100. Positive weekly observations receive equal weight; lower past EPS alone does not disqualify them.

Outlook-adjusted valuation: 71.3/100. The model applies a 13.8% earnings-growth assumption and a 10% annual return hurdle, with positive credit limited by evidence coverage and confidence.

Forward price scenarios use recent PE history separately. Recent history has a separately weighted median of 26.5× (18-month half-life). The favorable scenario uses 24.9× PE and $1.3 projected EPS, informed by growth, margins and earnings-quality checks. This is a model scenario, not an analyst target. A return to the full-history median is not assumed.

Cash flow & growth

Business trends are strong. Over the past year: revenue +17.2%, earnings +74.2%, operating margin +3.7 percentage points. Free cash flow is 7.6% of revenue. The business score is 78.6/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Favorable scenario

Stronger earnings and valuation could support a higher share price.

Our favorable case uses $1.33 of EPS and a 24.9× PE, suggesting a share price of about $33.21. Valuation history and outlook inform the PE.

The displayed favorable scenario is 51.9% upside, or about $33.22.

This is a scenario based on our model, not a forecast or probability.

Downside scenario

Weaker than expected earnings could put pressure on the share price.

Our downside case uses $0.91 of EPS and a 15.1× PE, suggesting a share price of about $13.78 — 37% below today’s price. Valuation history and outlook inform the PE.

This is a scenario based on our model, not a forecast or probability.

TCMD vs Historical averages

MetricCurrentAverageRelative
PE20x67x70% lower
PE percentile345033% lower
EPS$1.08$0.17537% higher
FCF$26.7M$19.6M36% higher
Loading historical comparisons…

TCMD’s earnings and cash flow are above their historical averages, while its earnings multiple is lower.

TCMD Forward outlook

MetricOutlook
Forward valuationStable
Forward earningsStable
Forward revenueGrowth
Forward profitabilityContracting
Analyst coverageLimited
Estimate dispersionModerate

TCMD’s outlook is mixed, with narrowing profit margins the main concern.

TCMD PE Valuation

Loading pe valuation table…

This table applies TCMD's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

TCMD Earnings Per Share

Loading earnings per share…

This chart tracks TCMD's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

TCMD Quarterly Revenue

Loading quarterly revenue…

This chart tracks TCMD's quarterly revenue over time and shows how sales are changing from year to year.

TCMD Free Cash Flow

Loading free cash flow…

This chart tracks TCMD's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

TCMD Total Shares

Loading shares over time…

This chart tracks changes in TCMD's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.

TCMD Net Leverage

Loading net leverage…

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

TCMD PE vs Healthcare Sector

Loading pe vs sector average…

This chart compares TCMD's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.

TCMD Weekly Price

Loading weekly price…

This chart uses TCMD's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

TCMD Weekly Moving Averages

Loading weekly moving averages…

This chart compares TCMD's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

TCMD Yearly ROI

Loading yearly ROI…

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.